March 2, 2023 09:59 AM ESTUpdated 01:24 PM
People
Pharma
Manufacturing

Ako­rn Phar­ma­ceu­ti­cals files for bank­rupt­cy, clos­es fa­cil­i­ties and will liq­ui­date

Tyler Patchen

News Reporter

The gener­ic drug man­u­fac­tur­er Ako­rn Phar­ma­ceu­ti­cals has filed for bank­rupt­cy and will close its fa­cil­i­ties across the US, liq­ui­date its as­sets and end op­er­a­tions, it …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

A service from the Financial Times